RNA-seq analysis on SW480 cells treated with or without YH-620 under hypoxia

To globally assess the role of alternatively translated 63 kDa NKRF, we performed and report on RNA-seq analysis on SW480 cells treated with or without novel small molecule HIF antagonist YH-620 under hypoxia. This study provides a framework for understanding the effect of novel small molecule HIF antagonist YH-620 on downstream targets. In addition, we also performed RNA-seq analysis on SW480 cells treated with or without specific small molecule CBP/catenin antagonist ICG-001 under hypoxia. Overall design: Examination of effect of YH-620 treatment on SW480 cells.